Adaptive Biotechnologies
ADPT
ADPT
133 hedge funds and large institutions have $2.58B invested in Adaptive Biotechnologies in 2019 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 44 increasing their positions, 29 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
4.13% more ownership
Funds ownership: 65.29% → 69.42% (+4.1%)
3% more capital invested
Capital invested by funds: $2.5B → $2.58B (+$87.1M)
68% less call options, than puts
Call options by funds: $1.61M | Put options by funds: $4.99M
Holders
133
Holding in Top 10
5
Calls
$1.61M
Puts
$4.99M
Top Buyers
| 1 | +$44.7M | |
| 2 | +$37.7M | |
| 3 | +$16M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$12.7M |
| 5 |
TCM
TimesSquare Capital Management
New York
|
+$11.6M |
Top Sellers
| 1 | -$32M | |
| 2 | -$13.9M | |
| 3 | -$12.3M | |
| 4 |
LCM
Laurion Capital Management
New York
|
-$5.47M |
| 5 |
Millennium Management
New York
|
-$5.28M |